And with that, I will turn the call over to Don Wood to begin our discussion of our fourth quarter results. Don Wood: Thank ...

Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...

And thank you all for joining us at our Q4 and 12 months 2024 Conference Call. I’m Harry Vafias, the CEO of Imperial Petroleum; and joining us today is Fenia Sakellari who will be discussing our ...

Wendy’s navigated a pressured fast-food category in 2024 on three fronts—technology, innovation, and breakfast, the latter of ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

UC SANTA BARBARA, Calif. - The UC Santa Barbara Women's Basketball team (14-10, 8-6 Big West) earned a crucial 62-52 win over ...

H1 2024-25 results in line with expectations Operating verticals revenues of €600m up 3.9% like-for-like1 Adjusted EBITDA margin of 55.2% FY 2024-25 objectives confirmed ...

Home loan approvals rose across 2024’s final quarter as the market eagerly anticipates what’s next for interest ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company” or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic ...

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q1 2025 Earnings Call Transcript February 12, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is ...